首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1304593

全球必需脂肪酸市場 - 2023-2030

Global Essential Fatty Acids Market - 2023-2030

出版日期: 2023年07月07日 | 出版商:

DataM Intelligence | 英文 102 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

全球必需脂肪酸市場規模在2022年達到46億美元，預計到2030年將達到85億美元，實現利潤豐厚的成長。在2023-2030年的預測期內，該市場的年複合成長率為8.1%。

全球對健康和保健的關注與日俱增，這使得消費者越來越意識到營養對整體健康的重要性。消費者積極尋找能夠提供健康益處的膳食干涉措施和補充劑，其中包括推動市場成長的必需脂肪酸（EFA）。

這種日益成長的趨勢推動了全球對EFA產品的需求。此外，除膳食補充劑外，EFA還被應用於其他領域，尤其是功能性食品和飲料領域。製造商將EFAs添加到各種產品中，如強化飲料、能量棒、穀物和烘焙食品。透過在功能性食品中添加EFAs。消費者可以方便地在日常飲食中攝入這些必需營養素。

市場動態

慢性病發病率的上升推動了必需脂肪酸市場的成長

隨著心血管疾病、糖尿病、肥胖症和神經系統疾病等慢性疾病的發病率不斷上升，人們越來越重視預防保健。根據美國疾病控制和預防中心的資料，每年有4100萬人死於非傳染性疾病，相當於全球每10人中就有7人死於非傳染性疾病。消費者變得更加積極主動地管理自己的健康，並尋求降低患慢性病風險的方法。因此，人們對必需脂肪酸（EFAs）的需求越來越高，將其作為支持整體健康和降低慢性疾病風險的預防措施。

EFAs因其對各種慢性疾病的潛在治療作用而廣泛研究。例如，Omega 3脂肪酸在治療心血管疾病、關節炎、抑鬱症和認知能力下降等疾病方面顯示出良好的效果。隨著人們對EFAs治療潛力的認知不斷提高，醫護人員和患者將EFAs涵蓋治療計劃和飲食方案。這種日益成長的認知推動了市場對EFAs的需求。

EFA在各行各業的應用範圍不斷擴大，推動了必需脂肪酸市場的成長

EFAs在各行各業的應用範圍不斷擴大，使市場多樣化並促進了市場成長。 EFAs，尤其是Omega-3脂肪酸，在製藥行業獲得了極大的關注。這些脂肪酸對心血管疾病、炎症性疾病、精神疾病和神經退行性疾病等各種健康狀況具有潛在的治療作用。 EFAs在個人護理和化妝品行業的應用日益廣泛。這些脂肪酸具有促進皮膚健康、保濕和抗衰老的功效。

必需脂肪酸，尤其是Omega-3脂肪酸，在嬰兒發育中發揮非常重要的作用。它們對大腦發育、認知功能和視覺敏銳度非常重要。 EFA對動物的健康和福利非常重要。它們廣泛用作動物飼料中的營養補充劑，以促進生長、改善免疫功能並提高家畜和水產養殖物種的整體健康水準。因此，EFA在製藥、個人護理、嬰幼兒營養、動物飼料、功能性食品和膳食補充劑中的應用範圍不斷擴大，推動了其市場的成長。

原料供應有限制約了必需脂肪酸市場的成長

EFAs，如Omega-3脂肪酸EPA（二十碳五烯酸）和DHA（二十二碳六烯酸），主要來源於魚類和藻類等海洋生物。由於過度捕撈、環境條件和法規限制等因素，這些來源的可獲得性可能有限。對特定來源的依賴使得原料供應易受波動和供應鏈中斷的影響。這種限制會限制EFAs的生產和供應，阻礙市場成長。

EFAs原料的可獲得性會受到季節性變化和收穫挑戰的影響。例如，某些魚類物種的捕撈或用於生產Omega-3脂肪酸的藻類培育可能僅限於特定季節或地區。這可能造成供應限制，影響全年EFA的穩定生產。市場參與者必須應對這些挑戰，以確保原料的穩定供應。

COVID-19影響分析

COVID-19影響分析包括COVID前情景、COVID情景和COVID後情景，以及定價動態（包括大流行期間和之後的定價變化，並與COVID前情景進行比較）、供需關係（由於貿易限制、封鎖和後續問題導致的供需變化）、政府計劃（政府機構為振興市場、行業或產業而採取的計劃）和製造商戰略計劃（此處將涵蓋製造商為緩解COVID問題而採取的措施）。

Market Overview

The Global Essential Fatty Acids Market reached US$ 4.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 8.5 billion by 2030. The market is growing at a CAGR of 8.1% during the forecast period 2023-2030.

The global focus on health and wellness is growing, which has led to increased consumer awareness about the significance of nutrition in overall well-being. Consumers are actively searching for dietary interventions and supplements that provide health benefits including essential fatty acids (EFAs) which drive the market growth.

This increasing trend is driving the global demand for EFA products. Additionally, EFAs are being utilized in applications beyond dietary supplements, particularly in the functional foods and beverages sector. Manufacturers are incorporating EFAs into various products such as fortified beverages, energy bars, cereals, and bakery items. By integrating EFAs into functional foods. Consumers can conveniently include these essential nutrients in their regular diets

Market Dynamics

Increasing Prevalence of Chronic Diseases Fuels the growth of the Essential Fatty Acids Market

With the increasing burden of chronic diseases, such as cardiovascular diseases, diabetes, obesity, and neurological disorders, there is a growing emphasis on preventive healthcare. According to the Centers for Disease Control and Prevention, each year, NCDs kill 41 million people, which is equivalent to more than 7 out of 10 people worldwide. Consumers are becoming more proactive in managing their health and seeking ways to reduce the risk of developing chronic conditions. As a result, there is a higher demand for essential fatty acids (EFAs) as a preventive measure to support overall well-being and reduce the risk of chronic diseases.

EFAs have been extensively studied for their potential therapeutic effects on various chronic diseases. For example, Omega 3 fatty acids have shown promising results in managing conditions such as cardiovascular diseases, arthritis, depression, and cognitive decline. As awareness regarding the therapeutic potential of EFAs grows healthcare professionals and patients are incorporating EFAs into treatment plans and dietary regimens. This growing recognition drives the demand for EFAs in the market.

Expanding Application Scope of EFAs Across Various Industries Fuels the Market Growth Of Essential Fatty Acids

The expanding application scope of EFAs across various industries diversifies the market and fuels the market growth. EFAs, particularly Omega-3 fatty acids, have gained significant attention in the pharmaceutical industry. These fatty acids have shown potential therapeutic benefits in various health conditions such as cardiovascular diseases, inflammatory disorders, psychiatric disorders, and neurodegenerative diseases. EFAs are increasingly being utilized in the personal care and cosmetics industry. These fatty acids offer benefits for skin health, hydration, and anti-aging properties.

Essential fatty acids, especially Omega-3 fatty acids, play a crucial role in infant development. They are vital for brain development, cognitive function, and visual acuity. EFAs are essential for animal health and well-being. They are widely used as nutritional supplements in animal feed to promote growth, improve immune function, and enhance overall health in livestock and aquaculture species. Hence, EFA's expanding range of applications in pharmaceuticals, personal care, infant nutrition, animal feed, functional foods, and dietary supplements is driving its market growth.

Limited Availability of Raw Materials is Restraining the Market Growth Of Essential Fatty Acids Market

EFAs, such as Omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are predominantly sourced from marine organisms like fish and algae. These sources may have limited availability due to factors such as overfishing, environmental conditions, and regulatory restrictions. The reliance on specific sources makes the availability of raw materials vulnerable to fluctuations and supply chain disruptions. This constraint can limit the production and availability of EFAs, hindering market growth.

The availability of raw materials for EFAs can be affected by seasonal variations and challenges in harvesting. For example, the harvesting of certain fish species or the cultivation of algae for Omega-3 fatty acids may be limited to specific seasons or regions. This can create supply constraints and impact the consistent production of EFAs throughout the year. Market players must navigate these challenges to ensure a stable supply of raw materials.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global essential fatty acids market is segmented based on product type, form, application, distribution channel, and region.

The Abundance of Omega-3 Fatty Acids in Fish

Based on source, essential fatty acids are classified into vegetable oils, meat, fish, seeds, nuts, and others.

In 2022, fish had the highest share in the essential fatty acids market. The fish segment is commonly recognized as one of the significant sources of Essential Fatty Acids (EFAs), particularly Omega-3 fatty acids. Fish, especially fatty fish like salmon, mackerel, and sardines, are known for their high Omega-3 content, specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). As a result, the fish segment often holds a prominent share in the EFAs market.

Fatty fish species are known to naturally accumulate Omega-3 fatty acids in their tissues. This natural abundance makes fish a valuable source for extracting EFAs, particularly EPA and DHA. The high Omega-3 content in fish contributes to the segment's significant market share.

Geographical Analysis

Growing Awareness of the Role of EFAs in the Asia-Pacific Region

In 2022, Asia Pacific has a significant share of the EFAs market. According to the Department of Biotechnology, India, India has the highest number of people with Diabetes in the world with around 77 million living with diabetes and a projection of 134 million by 2045 (International Diabetes Federation). India suffers loss of life at an early age due to cardiovascular disease which accounts for one-fourth of all deaths. EFAs, particularly Omega-3 fatty acids, have been extensively studied for their potential cardiovascular benefits, including reducing triglyceride levels, improving heart health, and managing blood pressure. The growing awareness of the role of EFAs drives the demand for EFAs products in the region.

Many countries in the Asia Pacific region have a long history of consuming Omega-3-rich foods, such as fish and seafood. Traditional diets in countries like Japan and South Korea include a significant amount of fish, which naturally provides Omega-3 fatty acids. This cultural preference and familiarity with Omega-3-rich foods contribute to the demand for EFAs in the region.

Competitive Landscape

The major global players include: Kemin Industries, Inc, KD Pharma Group, SEPPIC, Aker BioMarine AS, Koninklijke DSM NV, Croda International Plc, The Dow Chemical Company, Arbee Agencies, Arjuna Natural LLC, Arctic Nutrition.

Why Purchase the Report?

To visualize the global Essential Fatty Acids extract market segmentation based on product type, form, source, application, and region understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous Essential Fatty Acids extract market-level data points all for segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The Global Essential Fatty Acids Extract Market Report Would Provide Approximately 69 Tables, 74 Figures And 102 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Form
3.3. Snippet by Source
3.4. Snippet by Application
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Awareness of the Health Benefits of EFAs
  - 4.1.1.2. Increasing Nutritional Deficiencies
- 4.1.2. Restraints
  - 4.1.2.1. The High Cost of Production
- 4.1.3. Opportunity
  - 4.1.3.1. Market Expansion and Product Development
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Omega 3*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Omega 6
7.4. Omega 7
7.5. Omega 9

8. By Form

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2. Market Attractiveness Index, By Form
8.2. Powder*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Syrup
8.4. Oil
8.5. Others

9. By Source

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.1.2. Market Attractiveness Index, By Source
9.2. Vegetable Oils*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Meat
9.4. Fish
9.5. Seeds
9.6. Nuts
9.7. Others

10. By Application

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.1.2. Market Attractiveness Index, By Application
10.2. Nutraceuticals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Infant Formula
10.4. Pharmaceuticals
10.5. Cosmetics
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. The U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. The U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application